Cite
HARVARD Citation
Boudreau, G. et al. (2022). OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study. Canadian journal of neurological sciences. pp. 540-552. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boudreau, G. et al. (2022). OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study. Canadian journal of neurological sciences. pp. 540-552. [Online].